Drug intelligence / Profile preview

rTAT-PTD-Trp2Δ

Development stage
Preclinical
Modality
Peptide Conjugates → Peptides
Administration
Experimental/in Vitro (commonly Used In Cell Culture Or Preclinical Settings), Intradermal Or Intravenous (potential, Based On Typical Cpp Conjugate Use)
01

Overview

rTAT-PTD-Trp2Δ is an experimental **cell-penetrating peptide (CPP) conjugate** designed to deliver the Trp2Δ peptide sequence into cells. The rTAT component serves as a potent cell-penetrating peptide, increasing membrane permeability to enable intracellular delivery. The drug is typically researched for its utility in facilitating intracellular delivery of biologically active peptide sequences, especially for modulating immune responses or intracellular protein-protein interactions. The precise mechanism of action depends on the cargo peptide (here Trp2Δ), but generally, the rTAT-PTD enables cytosolic transport, potentially for antitumor immunomodulation or related peptide therapeutics. There is no evidence of commercial availability or advanced clinical development for this specific conjugate[6].

Other names
rTAT-PTD-Trp2Δ

Beyond the preview

Go deeper on rTAT-PTD-Trp2Δ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rTAT-PTD-Trp2Δ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call